Summary of Study ST003152

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001941. The data can be accessed directly via it's Project DOI: 10.21228/M8TM76 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST003152
Study TitleMetabolomics analysis of murine xenograft tumors derived from human breast cancer cell line MCF7 1 h after isotopic glucose bolus
Study TypeIntracellular metabolomics, [U-13C6] glucose tracing
Study SummaryMetabolomics analysis of murine xenograft tumors derived from human breast cancer cell line MCF7 1 h after isotopic glucose bolus. The NSG female mice were ~55 days after grafting tumors. [U-13C6] D-Glucose bolus was delivered intraperitoneally with a 10 mg/kg dose of Fasnall.
Institute
Wistar Institute
DepartmentMolecular and Cellular Oncogenesis Program, Ellen and Ronald Caplan Cancer Center
LaboratorySchug's Lab
Last NameMukha
First NameDzmitry
Address3601 Spruce St, Philadelphia, PA 19104, USA
Emaildmukha@wistar.org
Phone2154956903
Submit Date2024-03-09
Num Groups2
Total Subjects12
Num Females12
PublicationsSubmission Pending
Raw Data AvailableYes
Raw Data File Type(s)mzXML, raw(Thermo)
Analysis Type DetailLC-MS
Release Date2024-04-02
Release Version1
Dzmitry Mukha Dzmitry Mukha
https://dx.doi.org/10.21228/M8TM76
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR001941
Project DOI:doi: 10.21228/M8TM76
Project Title:The shutdown of NADH oxidation via Respiratory Complex I mimics fatty acid biosynthesis inhibition
Project Type:LC-MS Quantitative Analysis
Project Summary:Proliferating cancer cells actively utilize anabolic processes for biomass production, including de novo biosynthesis of amino acids, nucleotides, and fatty acids. The key enzyme of the fatty acid biosynthesis pathway, fatty acid synthase (FASN), is widely recognized as a promising therapeutic target in cancer and other health conditions. Here, we establish a metabolic signature of FASN inhibition using a panel of pharmacological inhibitors (GSK2194069, TVB-2640, TVB-3166, C75, cerulenin, and Fasnall). We find that the activity of some commonly used FASN inhibitors is inconsistent with the metabolic signature of FASN inhibition (accumulation of malonate, succinate, malonyl coenzyme A, succinyl coenzyme A, and other metabolic perturbations). Moreover, we show that one of these putative FASN inhibitors, Fasnall, is a respiratory Complex I inhibitor that mimics FASN inhibition through NADH accumulation and consequent depletion of the tricarboxylic acid cycle metabolites. We demonstrate that Fasnall impairs tumor growth in several oxidative phosphorylation-dependent cancer models, including combination therapy-resistant melanoma patient-derived xenografts. Fasnall administration does not reproduce neurological side effects in mice reported for other Complex I inhibitors. Our results have significant implications for understanding the FASN role in human health and disease and provide evidence of therapeutic potential for Complex I inhibitors with fast systemic clearance. Our findings also highlight the continuing need for validation of small molecule inhibitors to distinguish high-quality chemical probes and to expand the understanding of their application.
Institute:Wistar Institute
Department:Molecular and Cellular Oncogenesis Program, Ellen and Ronald Caplan Cancer Center
Laboratory:Schug's Lab
Last Name:Mukha
First Name:Dzmitry
Address:3601 Spruce St., Philadelphia, Pennsylvania 19104, USA
Email:dmukha@wistar.org
Phone:+12154956903
Funding Source:This work was supported by grants from the National Institutes of Health (NIH) National Cancer Institute (NCI) DP2 CA249950-01 (Z.T.S.), NIH NCI P01 CA114046 (Z.T.S.), Melanoma Research Foundation 717173 (Z.T.S.), and Susan G. Komen CCR19608782 (Z.T.S.).
Publications:Submission Pending
Contributors:Dzmitry Mukha, Jena Dessain, Seamus O’Connor, Katherine Pniewski, Fabrizio Bertolazzi, Jeet Patel, Mary Mullins, Zachary T. Schug

Subject:

Subject ID:SU003269
Subject Type:Mammal
Subject Species:Mus musculus
Taxonomy ID:10090
Genotype Strain:NOD Scid Gamma (NSG)
Age Or Age Range:~4.5 months
Weight Or Weight Range:24.3 +/- 1.9 g (mean +/- SD)
Gender:Female
Animal Housing:Wistar Animal Facility
Species Group:Mammals

Factors:

Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)

mb_sample_id local_sample_id Sample source Isotopic Tracer Drug Treatment
SA34098080MeOH_Blank_20230918155328NA NA NA
SA34098180MeOH_Blank_20230918220912NA NA NA
SA340982135standard_091823_1NA NA NA
SA340983135standard_091823_2NA NA NA
SA34098480MeOH_BlankNA NA NA
SA34098580MeOH_Blank_20230918223604NA NA NA
SA34098680MeOH_Blank_20230918145946NA NA NA
SA34098704_Fasnall_MCF7_Tum_Gluc_1h_F_1070Xenograft tumors 1 g/kg [U-13C6] D-glucose in PBS 10 mg/kg Fasnall
SA34098803_Fasnall_MCF7_Tum_Gluc_1h_F_1069Xenograft tumors 1 g/kg [U-13C6] D-glucose in PBS 10 mg/kg Fasnall
SA34098905_Fasnall_MCF7_Tum_Gluc_1h_F_1071Xenograft tumors 1 g/kg [U-13C6] D-glucose in PBS 10 mg/kg Fasnall
SA34099006_Fasnall_MCF7_Tum_Gluc_1h_F_1072Xenograft tumors 1 g/kg [U-13C6] D-glucose in PBS 10 mg/kg Fasnall
SA34099101_Fasnall_MCF7_Tum_Gluc_1h_F_1066Xenograft tumors 1 g/kg [U-13C6] D-glucose in PBS 10 mg/kg Fasnall
SA34099207_Fasnall_MCF7_Tum_Gluc_1h_F_1073Xenograft tumors 1 g/kg [U-13C6] D-glucose in PBS 10 mg/kg Fasnall
SA34099302_Fasnall_MCF7_Tum_Gluc_1h_F_1068Xenograft tumors 1 g/kg [U-13C6] D-glucose in PBS 10 mg/kg Fasnall
SA34099410_Fasnall_MCF7_Tum_Gluc_1h_D_1077Xenograft tumors 1 g/kg [U-13C6] D-glucose in PBS Vehicle
SA34099508_Fasnall_MCF7_Tum_Gluc_1h_D_1074Xenograft tumors 1 g/kg [U-13C6] D-glucose in PBS Vehicle
SA34099609_Fasnall_MCF7_Tum_Gluc_1h_D_1075Xenograft tumors 1 g/kg [U-13C6] D-glucose in PBS Vehicle
SA34099711_Fasnall_MCF7_Tum_Gluc_1h_D_1079Xenograft tumors 1 g/kg [U-13C6] D-glucose in PBS Vehicle
SA34099812_Fasnall_MCF7_Tum_Gluc_1h_D_1080Xenograft tumors 1 g/kg [U-13C6] D-glucose in PBS Vehicle
Showing results 1 to 19 of 19

Collection:

Collection ID:CO003262
Collection Summary:Tissue metabolite extracts were prepared from ~50 mg snap-frozen tissue samples. Each sample was weighed while frozen. Frozen samples were ground at the temperature of liquid nitrogen by Retch Cryomill. Then, 80% methanol was added to each tube at a ratio of 1 ml per 50 mg of tissue.
Collection Protocol Filename:DM_metabolomics_samples.txt
Sample Type:Tumor cells
Collection Method:80% methanol extraction
Volumeoramount Collected:~1 ml
Storage Conditions:-80℃
Collection Vials:1.5 ml plastic centrifuge tubes
Storage Vials:1.5 ml plastic centrifuge tubes

Treatment:

Treatment ID:TR003278
Treatment Summary:Animals received 1 g/kg [U-13C6] D-glucose bolus intraperitoneally with a 10 mg/kg dose of Fasnall.
Treatment Compound:Fasnall
Treatment Route:Intraperitoneal injection
Treatment Dose:10 mg/kg
Treatment Dosevolume:50 ul
Treatment Doseduration:1 h
Treatment Vehicle:1:1 DMSO/PBS
Animal Anesthesia:None
Animal Fasting:None
Animal Endp Euthanasia:CO2
Animal Endp Tissue Coll List:50 mg tumor samples

Sample Preparation:

Sampleprep ID:SP003276
Sampleprep Summary:Tissue metabolite extracts were prepared from ~50 mg snap-frozen tissue samples. Each sample was weighed while frozen. Frozen samples were ground at the temperature of liquid nitrogen by Retch Cryomill. Then, 80% methanol was added to each tube at a ratio of 1 ml per 50 mg of tissue. All samples were centrifuged at 18,000 g and 4 °C for 20 min. The supernatant was then transferred to new Eppendorf tubes and centrifuged again with the same parameters. After centrifugation, the extracts were transferred to glass LC-MS vials.
Sampleprep Protocol Filename:DM_metabolomics_samples.txt
Extraction Method:80% methanol
Extract Enrichment:None
Extract Cleanup:None
Extract Storage:-80℃
Sample Resuspension:None
Sample Derivatization:None
Sample Spiking:None
Subcellular Location:Intracellular metabolites

Chromatography:

Chromatography ID:CH003912
Instrument Name:Thermo Dionex Ultimate 3000 RS
Column Name:Merck SeQuant ZIC-pHILIC (150 x 2.1mm,5um)
Column Temperature:40
Flow Gradient:A linear solvent gradient of a total duration 22.5 min was starting with 0.2 ml/min flow rate of 80% solvent B, 12.5 min – 30%, 15 min – 30%, 15.2 min – 80%, 20 min – 80%, 21 min – flow rate 0.3 ml/min, 22 min – flow rate 0.3 ml/min, 22.1 min – flow rate 0.2 ml/min.
Flow Rate:0.2 ml/min
Solvent A:100% Water; 0.01% ammonium hydroxide; 20 mM ammonium bicarbonate
Solvent B:100% Acetonitrile
Chromatography Type:HILIC

Analysis:

Analysis ID:AN005171
Laboratory Name:Wistar Institute Proteomics & Metabolomic Core
Analysis Type:MS
Operator Name:Nicole Gorman
Detector Type:Orbitrap
Chromatography ID:CH003912
Num Factors:3
Num Metabolites:65
Rt Units:Minutes
Units:AU
  
Analysis ID:AN005172
Laboratory Name:Wistar Institute Proteomics & Metabolomic Core
Analysis Type:MS
Operator Name:Nicole Gorman
Detector Type:Orbitrap
Chromatography ID:CH003912
Num Factors:3
Num Metabolites:69
Rt Units:Minutes
Units:AU
  logo